|
|
Volumn 19, Issue 1, 2002, Pages 25-33
|
|
Effect of topotecan infusion duration on hematologic toxicity in recurrent ovarian carcinoma
a
|
|
Author keywords
Infusion duration; Infusions, parenteral; Ovarian neoplasms; Topotecan
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TOPOTECAN;
GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
FEMALE;
HEMATOLOGIC DISEASE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MIDDLE AGED;
MULTICENTER STUDY;
NEOPLASM;
OVARY TUMOR;
PATHOLOGY;
PROSPECTIVE STUDY;
TIME;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ANEMIA;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG INFUSION;
DRUG SAFETY;
DRUG TOLERABILITY;
LEUKOPENIA;
NEUTROPENIA;
OVARY CARCINOMA;
PRIORITY JOURNAL;
RECURRENT CANCER;
THROMBOCYTOPENIA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HEMATOLOGIC DISEASES;
HUMANS;
INFUSIONS, INTRAVENOUS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEOPLASMS, GLANDULAR AND EPITHELIAL;
OVARIAN NEOPLASMS;
PROSPECTIVE STUDIES;
TIME FACTORS;
TOPOTECAN;
TREATMENT OUTCOME;
HUMAN;
MIDDLE AGE;
|
|
EID: 0036015229
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1385/MO:19:1:25 Document Type: Article |
|
Times cited : (5)
|
|
References (25)
|
